Publicaciones en las que colabora con Marisa Crespo Leiro (20)

2024

  1. Diagnosing transthyretin amyloidosis in patients with known genetic cardiomyopathies - opportunities and open questions. Response

    Revista Espanola de Cardiologia

  2. Diagnosis of transthyretin amyloidosis in patients with established cardiomyopathy

    Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 347-349

2023

  1. Risks of Ventricular Arrhythmia and Heart Failure in Carriers of RBM20 Variants

    Circulation: Genomic and Precision Medicine, Vol. 16, Núm. 5, pp. 434-441

2021

  1. Clinical utility of genetic testing in patients with dilated cardiomyopathy

    Medicina Clinica, Vol. 156, Núm. 10, pp. 485-495

  2. Determinants of maximal oxygen uptake in patients with heart failure

    ESC Heart Failure, Vol. 8, Núm. 3, pp. 2002-2008

  3. Dilated cardiomyopathy and mild limb girdle muscular dystrophy caused by the p.Gly424Ser genetic variant in the fukutin gene

    Revista Espanola de Cardiologia, Vol. 74, Núm. 11, pp. 987-989

  4. Light chain and transthyretin cardiac amyloidosis: Clinical characteristics, natural history and prognostic factors

    Medicina Clinica, Vol. 156, Núm. 8, pp. 369-378

  5. Risk predictors in a Spanish cohort with cardiac laminopathies. The REDLAMINA registry

    Revista Espanola de Cardiologia, Vol. 74, Núm. 3, pp. 216-224

2020

  1. Diagnostic and prognostic value of cardiac imaging in amyloidosis

    World Journal of Cardiology, Vol. 12, Núm. 12, pp. 599-614

  2. Prognostic implications of pathogenic truncating variants in the TTN gene

    International Journal of Cardiology, Vol. 316, pp. 180-183

2019

  1. Cambio de paradigma en el diagnóstico y tratamiento de la amiloidosis cardiaca por transtirretina

    REC: CardioClinics, Vol. 54, Núm. 1, pp. 9-12

  2. Classification of Pulmonary Arterial Hypertension by Genetic and Familial Testing

    Revista Espanola de Cardiologia, Vol. 72, Núm. 7, pp. 591-593

  3. Paradigm shift in the diagnosis and treatment of transthyretin-related cardiac amyloidosis

    REC: CardioClinics, Vol. 54, Núm. 1, pp. 9-12

2018

  1. The importance of genotype-phenotype correlation in the clinical management of Marfan syndrome

    Orphanet Journal of Rare Diseases, Vol. 13, Núm. 1

2017

  1. ¿Cómo enfrentarse a una sospecha clínica de amiloidosis cardíaca? Un enfoque práctico para el diagnóstico

    Cardiocore, Vol. 52, Núm. 1, pp. 27-34

2016

  1. Estado serológico frente a Toxoplasma gondii en receptores de trasplante cardiaco: ¿un factor pronóstico independiente?

    Revista Espanola de Cardiologia, Vol. 69, Núm. 12, pp. 1160-1166

2015

  1. Atlas of the clinical genetics of human dilated cardiomyopathy

    European Heart Journal, Vol. 36, Núm. 18, pp. 1123-1135

2004

  1. Familial dilated cardiomyopathy and isolated left ventricular noncompaction associated with lamin A/C gene mutations

    American Journal of Cardiology, Vol. 94, Núm. 1, pp. 50-54

2003

  1. Radiology and Heart Transplant

    Radiologia, Vol. 45, Núm. 6, pp. 249-260

2002

  1. Familial dilated cardiomyopathy in patients transplanted for idiopathic dilated cardiomyopathy

    Revista Espanola de Cardiologia, Vol. 55, Núm. 7, pp. 725-732